Boldenone Undecylenate vs Nandrolone Phenylpropionate
A side-by-side research comparison of Boldenone Undecylenate and Nandrolone Phenylpropionate across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Boldenone Undecylenate | Nandrolone Phenylpropionate |
|---|---|---|
| Full name | Boldenone Undecylenate (Equipoise / EQ) | Nandrolone Phenylpropionate (NPP) |
| Category | Anabolic Steroids | Anabolic Steroids |
| Status | Veterinary drug (controlled substance) | Prescription drug (controlled substance) |
| Mechanism | Boldenone is a testosterone derivative with a double bond at the 1,2 position, giving moderate anabolic activity and low estrogen conversion. It stimulates erythropoiesis and appetite while binding androgen receptors. | Same active hormone as Deca (nandrolone) but with a shorter phenylpropionate ester, giving quicker onset and faster clearance. Acts on androgen receptors with high anabolic and reduced androgenic activity. |
| Molecular weight | 452.7 Da | 406.6 Da |
| Half-life | ~14 days | ~2.5-4.5 days |
| Bioavailability | Intramuscular injection | Intramuscular injection |
| Typical dose | Long cycles due to slow ester | Variable; more frequent than Deca |
| Frequency | Weekly | Every 2-3 days |
| Route | Intramuscular injection | Intramuscular injection |
Boldenone Undecylenate reported benefits
- Slow, steady lean gains
- Increased red blood cell count
- Appetite stimulation
- Low estrogen conversion
- Improved endurance (perceived)
Nandrolone Phenylpropionate reported benefits
- Lean mass gains
- Faster onset than Deca
- Faster clearance (flexibility)
- Reputed joint comfort
Related comparisons
Research and educational reference only. Not medical advice.